STOCK TITAN

Emergent BioSolutions: Oak Hill reports 7.5% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Oak Hill Advisors LP reported beneficial ownership of 4,014,015 shares of Emergent BioSolutions Inc. (EBS) common stock, equal to 7.5% of the class. The amount includes 2,500,000 shares issuable upon exercise of warrants. Oak Hill Advisors reported sole voting and dispositive power over 4,014,015 shares.

The percentage calculation uses 51,273,336 EBS shares outstanding as of July 30, 2026, and assumes exercise of the reported warrants. The Oak Hill Funds have the right to receive or direct dividends and sale proceeds from the reported shares.

Beneficial ownership 4,014,015 shares Reported by Oak Hill Advisors LP; includes shares issuable upon warrant exercise
Percent of class 7.5% Reported beneficial ownership percentage
Shares issuable upon warrant exercise 2,500,000 shares Included in reported beneficial ownership
Shares outstanding 51,273,336 shares As of July 30, 2026; used for the percentage calculation, which assumes warrant exercise
beneficially owned regulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Dispositive Power regulatory
"Sole Dispositive Power 4,014,015.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
warrants financial
"shares of Common Stock issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EBS shares does Oak Hill Advisors report owning?

Oak Hill Advisors reported beneficial ownership of 4,014,015 EBS shares, or 7.5% of the class. That amount includes 2,500,000 shares issuable upon exercise of warrants.

Who receives dividends or sale proceeds from Oak Hill's reported EBS shares?

The Oak Hill Funds have the right to receive or direct the receipt of dividends and proceeds from sales of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





29089Q105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 2,500,000 shares of Common Stock (as defined in Item 2(a)) issuable upon exercise of warrants.


SCHEDULE 13G



Oak Hill Advisors LP
Signature:/s/ William H. Bohnsack, Jr.
Name/Title:William H. Bohnsack, Jr., Authorized Signatory
Date:11/16/2026

Keep reading